MBrace Therapeutics Funding & Investors

MBrace Therapeutics is a privately held biopharmaceutical business dedicated to improving cancer patients' quality of life by developing antibody-drug conjugates (ADCs) against novel oncology targets.

Total Amount Raised: $110,000,000

MBrace Therapeutics Funding Rounds

Series B
$85,000,000
Nov 13, 2023
Series B Investors
Avidity Partners
Venrock
Alta Partners
TPG
Cowen
Series A
$25,000,000
Dec 31, 2020
Series A Investors
Venrock
Alta Partners

Funding info provided by Diffbot.